HRP20000340B1 - Derivati benzodioksana, benzofurana ili benzopirana koji imaju svojstva relaksacije fundusa - Google Patents

Derivati benzodioksana, benzofurana ili benzopirana koji imaju svojstva relaksacije fundusa

Info

Publication number
HRP20000340B1
HRP20000340B1 HR20000340A HRP20000340A HRP20000340B1 HR P20000340 B1 HRP20000340 B1 HR P20000340B1 HR 20000340 A HR20000340 A HR 20000340A HR P20000340 A HRP20000340 A HR P20000340A HR P20000340 B1 HRP20000340 B1 HR P20000340B1
Authority
HR
Croatia
Prior art keywords
alkyl
formula
alkyloxy
hydrogen
divalent radical
Prior art date
Application number
HR20000340A
Other languages
English (en)
Croatian (hr)
Inventor
Tom Bert Paul Wigerinck Piet
Gaston Verschueren Wim
Francis Josephine Schroven Marc
Frans Leopold De Bruyn Marcel
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of HRP20000340A2 publication Critical patent/HRP20000340A2/hr
Publication of HRP20000340B1 publication Critical patent/HRP20000340B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HR20000340A 1997-12-05 1998-11-27 Derivati benzodioksana, benzofurana ili benzopirana koji imaju svojstva relaksacije fundusa HRP20000340B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203808 1997-12-05
PCT/EP1998/007771 WO1999029687A1 (en) 1997-12-05 1998-11-27 (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties

Publications (2)

Publication Number Publication Date
HRP20000340A2 HRP20000340A2 (en) 2001-04-30
HRP20000340B1 true HRP20000340B1 (hr) 2008-12-31

Family

ID=8229014

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000340A HRP20000340B1 (hr) 1997-12-05 1998-11-27 Derivati benzodioksana, benzofurana ili benzopirana koji imaju svojstva relaksacije fundusa

Country Status (31)

Country Link
US (4) US6133277A (cs)
EP (1) EP1036073B8 (cs)
JP (1) JP2001525407A (cs)
KR (1) KR100591605B1 (cs)
CN (1) CN1155597C (cs)
AR (1) AR017195A1 (cs)
AT (1) ATE334125T1 (cs)
AU (1) AU748669B2 (cs)
BG (1) BG64624B1 (cs)
BR (1) BR9814256A (cs)
CA (1) CA2311669C (cs)
CO (1) CO5011114A1 (cs)
CZ (1) CZ297895B6 (cs)
DE (1) DE69835372T2 (cs)
EA (1) EA003365B1 (cs)
EE (1) EE04438B1 (cs)
ES (1) ES2270541T3 (cs)
HR (1) HRP20000340B1 (cs)
HU (1) HU224813B1 (cs)
ID (1) ID24616A (cs)
IL (1) IL136529A (cs)
MY (1) MY124586A (cs)
NO (1) NO320727B1 (cs)
NZ (1) NZ503603A (cs)
PL (1) PL191144B1 (cs)
SK (1) SK286268B6 (cs)
TR (1) TR200001542T2 (cs)
TW (1) TW577886B (cs)
UA (1) UA70308C2 (cs)
WO (1) WO1999029687A1 (cs)
ZA (1) ZA9811081B (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
CA2374905C (en) * 1999-06-02 2010-02-23 Janssen Pharmaceutica N.V. Pyrrolidinyl, piperidinyl or homopiperidinyl-substituted benzopyran derivatives for treating impaired fundic relaxation
WO2000075136A1 (en) 1999-06-02 2000-12-14 Janssen Pharmaceutica N.V. Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
JO2352B1 (en) 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
US6688079B2 (en) 2001-04-18 2004-02-10 Kraft Foods Holdings, Inc. Method for manufacturing flexible packages having slide closures
EP1445324A4 (en) * 2001-11-09 2005-02-16 Kaneka Corp PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMAN DERIVATIVE AND INTERMEDIATE PRODUCT
ES2199086B1 (es) 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
US7071821B2 (en) * 2003-05-14 2006-07-04 Bellsouth Intellectual Property Corporation Method and system for alerting a person to a situation
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
WO2005032544A1 (en) 2003-09-19 2005-04-14 Galileo Pharmaceuticals, Inc. Treatment of mitochondrial diseases
BRPI0416206A (pt) 2003-11-20 2006-12-26 Janssen Pharmaceutica Nv 2-quinolinonas e 2-quinoxalinonas substituìdas por 6-alquenila e 6-fenilalquila como inibidores de polimerase de poli(adp-ribose)
BRPI0416817A (pt) 2003-11-20 2007-03-06 Janssen Pharmaceutica Nv 2-quinolinonas e 2-quinoxalinonas 7-fenilalquila substituìdas como inibidores da poli(adp-ribose)polimerase
ES2238015B1 (es) * 2004-01-30 2006-11-01 Cepa Schwarz Pharma, S.L. Derivados de cicloalcanodionas con actividad neuroprotectora.
JP5100376B2 (ja) * 2004-06-30 2012-12-19 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｐａｒｐ阻害剤としてのキナゾリンジオン誘導体
BRPI0512797A (pt) 2004-06-30 2008-04-08 Janssen Pharmaceutica Nv derivados de quinazolinona como inibidores de parp
BRPI0512902A (pt) 2004-06-30 2008-04-15 Janssen Pharmaceutica Nv derivados de ftalazina como inibidores de parp
RU2391350C2 (ru) * 2004-07-02 2010-06-10 Базелль Полиолефине Гмбх Способ рацемоселективного синтеза анса-металлоценов
DE102004032277A1 (de) * 2004-07-02 2006-01-19 Basell Polyolefine Gmbh Verfahren zur racemoselektiven Synthese von ansa-Metallocenen
PA8663501A1 (es) 2005-02-17 2006-11-09 Wyeth Wyeth Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilcondensados
TW200716595A (en) * 2005-04-22 2007-05-01 Wyeth Corp Chromane and chromene derivatives and uses thereof
WO2008015538A2 (en) * 2006-07-31 2008-02-07 Schwarz Pharma S.L. Use of diaza- and thiaza-cycloalkanediones for preventing and/or treating pain and /or migraine
US20080033050A1 (en) * 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US8503431B2 (en) * 2006-08-25 2013-08-06 Wireless Wonders Ltd. Mobile phone related indirect communication system and method
AU2008223793B2 (en) 2007-03-08 2012-08-23 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP and TANK inhibitors
JP5017703B2 (ja) * 2007-05-16 2012-09-05 住友ゴム工業株式会社 ビードエイペックスおよびタイヤ
WO2009053373A1 (en) 2007-10-26 2009-04-30 Janssen Pharmaceutica Nv Quinolinone derivatives as parp inhibitors
RU2490260C2 (ru) 2008-03-27 2013-08-20 Янссен Фармацевтика Нв Тетрагидрофенантридиноны и тетрагидроциклопентахинолиноны в качестве ингибиторов parp и ингибиторов полимеризации тубулина
EP2260026B1 (en) 2008-03-27 2011-06-22 Janssen Pharmaceutica, N.V. Quinazolinone derivatives as tubulin polymerization inhibitors
SMT201900506T1 (it) 2012-02-24 2019-11-13 Lupin Ltd Composti cromanici sostituiti come modulatori dei recettori sensibili al calcio
DE102012206062B4 (de) 2012-04-13 2019-09-12 Adidas Ag Schuhoberteil
US9040533B2 (en) 2012-12-27 2015-05-26 Purdue Pharma L.P. Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators
DE102013207163B4 (de) 2013-04-19 2022-09-22 Adidas Ag Schuhoberteil
DE102014220087B4 (de) 2014-10-02 2016-05-12 Adidas Ag Flachgestricktes Schuhoberteil für Sportschuhe
EP3397643A1 (en) 2015-12-30 2018-11-07 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Pt(IV) PRODRUGS

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) * 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
US3929801A (en) * 1973-11-20 1975-12-30 Janssen Pharmaceutica Nv 2-Benzimidazolinones
GB1599296A (en) * 1977-07-06 1981-09-30 Brewster D L Ice making machine
GR71865B (cs) * 1978-03-20 1983-07-07 Ciba Geigy
DE2852945A1 (de) * 1978-12-07 1980-06-26 Boehringer Sohn Ingelheim Benzodioxanyl-hydroxyaethylpiperidyl- imidazolidinone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
US4239348A (en) * 1979-11-30 1980-12-16 Hughes Aircraft Company High resolution AC silicon MOS light-valve substrate
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE4140540A1 (de) * 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
DE4319038A1 (de) * 1993-06-08 1994-12-15 Bayer Ag Verwendung von teilweise bekannten substituierten Chromanen als Arzneimittel, neue Wirkstoffe und Verfahren zu ihrer Herstellung
PL181385B1 (pl) * 1993-08-19 2001-07-31 Janssen Pharmaceutica Nv Nowe pochodne dihydrobenzopiranu o wlasciwosciach naczyniozwezajacych, kompozycja farmaceutyczna i sposób wytwarzania pochodnych dihydrobenzopiranu PL PL PL PL PL PL
US5541199A (en) * 1995-06-02 1996-07-30 American Home Products Corporation Chroman-2-ylmethylamino derivatives
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US5696653A (en) * 1996-12-13 1997-12-09 Phase Metrics Tooling for holding a head gimbal assembly
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties

Also Published As

Publication number Publication date
US6852714B2 (en) 2005-02-08
AR017195A1 (es) 2001-08-22
KR20010031010A (ko) 2001-04-16
CN1280577A (zh) 2001-01-17
US6495547B1 (en) 2002-12-17
US20030149093A1 (en) 2003-08-07
ZA9811081B (en) 2000-06-22
NO320727B1 (no) 2006-01-23
ES2270541T3 (es) 2007-04-01
IL136529A (en) 2003-03-12
SK8032000A3 (en) 2001-02-12
EP1036073B1 (en) 2006-07-26
CA2311669A1 (en) 1999-06-17
BG64624B1 (bg) 2005-09-30
UA70308C2 (uk) 2004-10-15
KR100591605B1 (ko) 2006-06-20
CZ297895B6 (cs) 2007-04-25
TW577886B (en) 2004-03-01
HK1028400A1 (en) 2001-02-16
NZ503603A (en) 2001-10-26
DE69835372T2 (de) 2007-08-09
EA003365B1 (ru) 2003-04-24
HRP20000340A2 (en) 2001-04-30
WO1999029687A1 (en) 1999-06-17
SK286268B6 (sk) 2008-06-06
HUP0004492A2 (hu) 2002-03-28
WO1999029687A8 (en) 2000-04-13
PL341007A1 (en) 2001-03-12
CN1155597C (zh) 2004-06-30
BR9814256A (pt) 2000-10-03
CZ20002018A3 (cs) 2000-10-11
EP1036073A1 (en) 2000-09-20
ID24616A (id) 2000-07-27
CO5011114A1 (es) 2001-02-28
EP1036073B8 (en) 2006-11-15
AU2412799A (en) 1999-06-28
NO20002074L (no) 2000-06-02
PL191144B1 (pl) 2006-03-31
HU224813B1 (en) 2006-02-28
NO20002074D0 (no) 2000-04-19
ATE334125T1 (de) 2006-08-15
IL136529A0 (en) 2001-06-14
HUP0004492A3 (en) 2002-04-29
DE69835372D1 (de) 2006-09-07
AU748669B2 (en) 2002-06-06
US6133277A (en) 2000-10-17
BG104372A (en) 2000-12-29
US6747045B2 (en) 2004-06-08
EA200000616A1 (ru) 2000-12-25
CA2311669C (en) 2010-04-27
EE04438B1 (et) 2005-02-15
US20030083365A1 (en) 2003-05-01
TR200001542T2 (tr) 2001-01-22
MY124586A (en) 2006-06-30
JP2001525407A (ja) 2001-12-11
EE200000328A (et) 2001-08-15

Similar Documents

Publication Publication Date Title
HRP20000340B1 (hr) Derivati benzodioksana, benzofurana ili benzopirana koji imaju svojstva relaksacije fundusa
AR035069A1 (es) Compuestos inhibidores de espiropirimidin-2,4,6-triona metaloproteinasas, composicion farmaceutica, procedimiento de tratamiento
KR960040357A (ko) 화장용 조성물 또는 약제학적 조성물의 제조에 사용되는 레티노이드의 용도
ATE275559T1 (de) Aromatische amin-derivate verwendbar als pharmazeutische mittel
EP1248612A4 (en) NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS
HU0102160D0 (en) Use of alpha-keto enamine derivatives as ingredients
MX9202287A (es) Nuevos derivados de perhidroisoindol, procedimiento para su preparacion y composicion farmaceutica que los contiene.
MEP33708A (hr) Farmaceutske smješe koje obuhvataju inhibitor hmg coa reduktaze
CO5150227A1 (es) Compuestos de triazol y su utilizacion
BR9712959A (pt) Compostos ou suas composições, e, uso de compostos ou de composições.
BG106013A (en) New compounds and compositions as protease inhibitors
AR016665A1 (es) Derivados de nitrilos de dipeptido, un proceso para su preparacion, una composicion farmaceutica que los comprende y el uso de los mismos para lafabricacion de un medicamento
BR9912033A (pt) Composições para lavar roupa e limpeza
YU96103A (sh) Novi derivati indola sa afinitetom za 5-ht6 receptor
AR018033A1 (es) Analogos 13-oxa prostaglandinas, composicion farmaceutica que los contiene y su uso para la manufactura de un medicamento
MA26904A1 (fr) Aminoalkyl 1-lactames substituees et leur utilisation en tant qu'antagonistes du recepteur muscarinique.
RS50173B (sr) Upotreba epinastina za lečenje alergijskog rinitisa/konjuktivitisa
ATE94061T1 (de) Arylsubstituierte aminderivate verwendbar in der krebstherapie.
MA26906A1 (fr) Aminoalkyl 1-lactames substituees et leur utilisation en tant qu'antagonistes du recepteur muscarinique
MXPA00003542A (es) Composiciones de colorante o tinte oxidante con acondicionamiento y deposicion mejorada del tinte.
DE69806962D1 (de) Verwendung von nmifa als entzündungshemmer in oberflächlichem saugetier-gewebe
IL108695A (en) Pharmaceutical composition comprising polyamine derivatives and some such novel compounds
IL104258A (en) a-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES514654A0 (es) "un procedimiento para preparar un compuesto de cefem".
BG99593A (en) Application of dtmethylbenzofurans as 5-ht3 antagonists

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20081126

Year of fee payment: 11

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20091128